{"id":36703,"date":"2022-02-25T12:15:00","date_gmt":"2022-02-25T11:15:00","guid":{"rendered":"https:\/\/fhi.nl\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/"},"modified":"2024-07-10T13:33:08","modified_gmt":"2024-07-10T11:33:08","slug":"de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker","status":"publish","type":"news","link":"https:\/\/fhi.nl\/en\/news\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/","title":{"rendered":"The impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients"},"content":{"rendered":"
\n\n\t\n\t\t\t
<\/div>\n\t\n\t
\n\t\t
\n\t\t\t
\n\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\tThe impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients\t\t\t\t<\/h1>\n\n\t\t\t\t
\n\t\t\t\t\t<\/svg>\t\t\t\t<\/div>\n\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\n\t\t\t\t\t\t\t
\n\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t<\/div>\n<\/header>\n\n\t
\n\t
\n\t\t
\n\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
Branch<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tLaboratory Technology\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
Subject<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tLaboratory Technology\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tLife Science\/Biotechnology\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n\t
\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t

In order to map the human genome, in which the complete genetic composition of man can be found, there are promising techniques such as next gen sequencing and whole genome sequencing. Ed Schuuring, Professor of Molecular Oncological Pathology and Clinical Molecular Biologist in Pathology at the UMCG, talks about a number of these developments.<\/strong><\/p>\r\n

By: Dimitri Reijerman<\/p>\r\n

Schuuring and his colleagues are researching cancer cells, among other things. He says:
\u201cWhen we receive a tumor biopsy, a piece of human tissue, in pathology, we have been looking for certain characteristics for a hundred years \u2013 ever since the microscope was invented \u2013 to see if it is cancer and if so, what type of cancer. In recent years, the field has improved greatly by, for example, looking at protein expressions that contribute to the staging and better classification of tumors. The new development is that we can now characterize tumors even better and provide more optimal treatments based on the genetic composition of a tumor.\u201d<\/p>\r\n

\u201cYou see that everything is slowly shifting towards molecular diagnostics, towards research methods that allow you to create a genetic tumor profile using next-gen sequencing, for example. I expect that pathologists will soon need the microscope much less often than we do at present.\u201d<\/p>\r\n

\u00a0\u201cAn important new development in the treatment of cancer patients is that for some genetic abnormalities found in the tumor, specific drugs are available that target the cancer cells with this abnormality,\u201d says the professor. \u201cWe have a list of about fifteen to thirty markers for which we have a targeted drug available. We call this customized therapy. The treatment of lung cancer is the most advanced in this respect. The official national guideline for lung cancer already mentions 12 genes that must be tested and for which, if an abnormality is found, targeted therapy is available. The drug in question must be included in the basic package, be regulated and easily available to all patients.<\/p>\r\n

More expensive but more efficient<\/strong><\/p>\r\n

Schuuring explains further: \u201cDevelopments are not standing still and more and more new drugs targeting abnormalities in yet other genes are becoming available that are effective in clinical studies. Although the costs for these tests are currently not fully reimbursed, we should also test for these genes in order to make the new targeted drugs accessible to all cancer patients. So as a patient, you would already want to be tested for a broad package of genes. I think that we should ultimately look at at least fifty genes. This would lead to a broad next-gen sequencing method, in which you do not look at one genetic abnormality but at many abnormalities at the same time. In fact, this would make a significant efficiency gain: the NGS test is somewhat more expensive than a single-gene test, but you do look at dozens of genes at the same time.\u201d<\/p>\r\n

And finally, there is whole genome sequencing (WGS): \u201cThese tests are relatively expensive, but they do map the entire genome (i.e. all genetic abnormalities) of a tumor. That is the shift, driven by all the new medicines that are coming. The use of WGS has several consequences, says Schuuring: \u201cSuppose you sequence the entire genome with WGS for lung cancer. This can reveal many different DNA abnormalities. But if you can't do anything with most of the information, then that is an important reason to not only use WGS but also broad NGS with which you can analyze more than 500 genes. An important consideration for using broad NGS tests is that these tests are not only used on fresh\/frozen tissue but also on embedded tissue (in paraffin blocks) that is stored as standard from all tissue in all pathology labs, and that broad NGS can currently identify all relevant DNA abnormalities. \u201cThat is why I do not expect widespread use of expensive WGS in current diagnostics in the coming years, except for very specific diagnostic questions such as in pediatric oncology or in cases of unknown primary tumor.\u201d<\/p>\r\n

\u201cThere is also a political side to it: how do these developments fit into current healthcare? I help advise the minister on how we can better organize healthcare over the next five years and offer every cancer patient in the Netherlands equal opportunities for access to all available targeted medicines. It is a completely different diagnostics than what we do now. It costs a lot of money and in the current setting we should start cutting back on healthcare sooner.\u201d<\/p>\t\t<\/div>\n\t<\/div>\n<\/div>\r\n\t

\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
<\/svg>

Related articles<\/h2><\/div>\t\t\t\t\t\t\t\t\t\t\t\t\tview profile<\/a>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\n\n\t
\n\t\t\n\n\n<\/mask>\n\n\n\n\n<\/g>\n<\/svg>\n\t<\/div>\n\t

75 million euros to strengthen the innovative power of SMEs<\/h3><\/div><\/div>\n\t
\n\t\t\n\t\t\n\t\t\t<\/div>\n\t
\n\t\t\t\t\t
\n\t\t\t\tFHI, Federation of Technology Industries\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\tJune 12, 2018\t\t\t<\/div>\n\t\t\t<\/div>\n<\/a>\n\n\n\t
\n\t\t\n\n\n<\/mask>\n\n\n\n\n<\/g>\n<\/svg>\n\t<\/div>\n\t

Reduce maintenance and extend lifespan<\/h3><\/div><\/div>\n\t
\n\t\t\n\t\t\n\t\t\t\t\t\tWorld of Industry, Technology & Science<\/span>\n\t\t\t\t\t\t\t\tMembers content<\/span>\n\t\t\t\t\t<\/div>\n\t
\n\t\t\t\t\t
\n\t\t\t\tAPEX Dynamics BV\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\tSeptember 21, 2022\t\t\t<\/div>\n\t\t\t<\/div>\n<\/a>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n
\n\t
\n\t\t
\n\t\t\t\t\t\t\t
<\/svg>

Related companies<\/h2><\/div>\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n\t
\"\"<\/div>\n\t
\"\"<\/div>\n\t
Engineering firm Gommer<\/div>\n\t
Engineering firm Gommer is active as a supplier of high-quality components and systems for the (petro)chemical industry. Engineering firm Gommer specializes in the design and production of (automated) sampling systems for liquids and\u2026<\/div>\n\t\t\t
View<\/a><\/div>\n\t<\/div>\n\n\n\n
\n\t
<\/div>\n\t
<\/div>\n\t
Micromeritics <\/div>\n\t
<\/div>\n\t\t\t
View<\/a><\/div>\n\t<\/div>\n\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":36704,"template":"","branches":[14],"events":[369],"secretariat":[],"categories":[59,32],"themes_tax":[],"content_types":[],"class_list":["post-36703","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nDe impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker<\/title>\n<meta name=\"description\" content=\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fhi.nl\/en\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\" \/>\n<meta property=\"og:description\" content=\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fhi.nl\/en\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/\" \/>\n<meta property=\"og:site_name\" content=\"FHI, federatie van technologiebranches\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-10T11:33:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fhi.nl\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/\",\"url\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/\",\"name\":\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\",\"isPartOf\":{\"@id\":\"https:\/\/fhi.nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg\",\"datePublished\":\"2022-02-25T11:15:00+00:00\",\"dateModified\":\"2024-07-10T11:33:08+00:00\",\"description\":\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\",\"breadcrumb\":{\"@id\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage\",\"url\":\"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg\",\"contentUrl\":\"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg\",\"width\":800,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fhi.nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nieuws\",\"item\":\"https:\/\/fhi.nl\/nieuws\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fhi.nl\/#website\",\"url\":\"https:\/\/fhi.nl\/\",\"name\":\"FHI, federatie van technologiebranches\",\"description\":\"Nederlandse branchevereniging voor technologiebranches\",\"publisher\":{\"@id\":\"https:\/\/fhi.nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fhi.nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fhi.nl\/#organization\",\"name\":\"FHI, federatie van technologiebranches\",\"url\":\"https:\/\/fhi.nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fhi.nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fhi.nl\/app\/uploads\/2024\/06\/3-e1722349014385.png\",\"contentUrl\":\"https:\/\/fhi.nl\/app\/uploads\/2024\/06\/3-e1722349014385.png\",\"width\":732,\"height\":136,\"caption\":\"FHI, federatie van technologiebranches\"},\"image\":{\"@id\":\"https:\/\/fhi.nl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/fhi-federation-of-technology-branches\",\"https:\/\/www.instagram.com\/fhi_nl\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients","description":"The impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fhi.nl\/en\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/","og_locale":"en_GB","og_type":"article","og_title":"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker","og_description":"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker","og_url":"https:\/\/fhi.nl\/en\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/","og_site_name":"FHI, federatie van technologiebranches","article_modified_time":"2024-07-10T11:33:08+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fhi.nl\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/","url":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/","name":"The impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients","isPartOf":{"@id":"https:\/\/fhi.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage"},"image":{"@id":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage"},"thumbnailUrl":"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg","datePublished":"2022-02-25T11:15:00+00:00","dateModified":"2024-07-10T11:33:08+00:00","description":"The impact of next gen sequencing and whole genome sequencing in the molecular diagnostics of cancer patients","breadcrumb":{"@id":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#primaryimage","url":"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg","contentUrl":"https:\/\/fhi.nl\/app\/uploads\/news\/68f3722599d270518fb4c08d663eb1ca-afbeelding_interview-ed-schuuring_sequencer-800x400.jpg","width":800,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/fhi.nl\/lifescience\/nieuws\/de-impact-van-next-gen-sequencing-en-whole-genome-sequencing-in-de-moleculaire-diagnostiek-van-patienten-met-kanker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fhi.nl\/"},{"@type":"ListItem","position":2,"name":"Nieuws","item":"https:\/\/fhi.nl\/nieuws\/"},{"@type":"ListItem","position":3,"name":"De impact van next gen sequencing en whole genome sequencing in de moleculaire diagnostiek van pati\u00ebnten met kanker"}]},{"@type":"WebSite","@id":"https:\/\/fhi.nl\/#website","url":"https:\/\/fhi.nl\/","name":"FHI, federation of technology industries","description":"Dutch trade association for technology industries","publisher":{"@id":"https:\/\/fhi.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fhi.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/fhi.nl\/#organization","name":"FHI, federation of technology industries","url":"https:\/\/fhi.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fhi.nl\/#\/schema\/logo\/image\/","url":"https:\/\/fhi.nl\/app\/uploads\/2024\/06\/3-e1722349014385.png","contentUrl":"https:\/\/fhi.nl\/app\/uploads\/2024\/06\/3-e1722349014385.png","width":732,"height":136,"caption":"FHI, federatie van technologiebranches"},"image":{"@id":"https:\/\/fhi.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/fhi-federation-of-technology-branches","https:\/\/www.instagram.com\/fhi_nl\/"]}]}},"_links":{"self":[{"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/news\/36703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":0,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/news\/36703\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/media\/36704"}],"wp:attachment":[{"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/media?parent=36703"}],"wp:term":[{"taxonomy":"branches","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/branches?post=36703"},{"taxonomy":"events","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/events?post=36703"},{"taxonomy":"secretariat","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/secretariat?post=36703"},{"taxonomy":"categories","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/categories?post=36703"},{"taxonomy":"themes","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/themes_tax?post=36703"},{"taxonomy":"content_types","embeddable":true,"href":"https:\/\/fhi.nl\/en\/wp-json\/wp\/v2\/content_types?post=36703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}